by in
Entry Author Date Location
Time to Cure Cancer or Stash Cash Under the Mattress? 08/15/11 National
Advanced Cell Technology Starts Human Trials of Embryonic Stem Cells Under Strict FDA Supervision 07/20/11 Boston
SeaGen’s Big Day at the FDA, Hutch Nabs $20M HIV Grant, Allozyne’s Nasdaq Plan, & More Seattle-Area Life Sciences News 07/14/11 Seattle
Fate Therapeutics Trims Chemistry Staff, Bets on Biotech Drugs 07/07/11 National
iPierian Shakeup Continues, as Chairman Corey Goodman, Scientist Doug Melton Exit Stem Cell Startup 06/15/11 San Francisco
Termeer Joins Verastem Board 06/13/11 Boston
At The Great Lakes Stem Cell (Innovation) Center, Researchers Anxiously Wait For Technology To Take Off 06/08/11 Detroit
Will Biotech Ever Again Captivate the Public Imagination, Like Facebook or LinkedIn? 05/16/11 National
iPierian, Stem Cell Startup With Big Science & Big Bucks, Axes Group of Top Executives 05/13/11 San Francisco
Takeda Bets on Fate Therapeutics 05/10/11 San Diego
Geron Nabs $25M Loan from Stem Cell Agency, Paves Way for State Support of Clinical Trials 05/05/11 San Francisco
StemCells Cuts 30% of Staff 05/04/11 San Francisco
Q&A: UCSF’s Jeff Bluestone on the Tricky Balancing Act Between Academia and Industry 03/10/11 San Francisco
Fate CEO Exits for New Co 02/22/11 San Diego
Flagship VentureLabs, Creating and Spinning Out Cleantech and Life Sciences Startups for 10 Years, Takes the Veil Off 02/17/11 Boston
Fluidigm Completes IPO on 2nd Try, Geron CEO Exits, Amgen Pushes ‘Son of Dmab,’ & More Bay Area Life Sciences News 02/11/11 San Francisco
Fluidigm Raises $75M in Second Chance at IPO 02/10/11 San Francisco
Geron CEO Steps Down 02/09/11 San Francisco
Axonia Seeks to Regenerate Nerves a New Way, Sidestepping Stem Cell Controversy 01/25/11 Detroit
Follica Co-Founder and Team Find New Clues About Male Baldness 01/04/11 Boston
John Mendlein, Biotech Exec With Surfer Look, Follows Winding Path as “Parallel Entrepreneur” 01/03/11 San Diego
Fluidigm, Maker of Genomic Tools, Takes Second Crack at IPO, Hoping for Less Drama 12/14/10 San Francisco
Aastrom Announces $22.5M Public Offering to Help Fund Stem Cell Trials 12/10/10 Detroit
How to Raise Money for an Honest-to-God Innovative Biotech Startup: Highlights from Convergence 12/06/10 National
Aastrom Maps Out Pivotal Trial Strategy With Adult Stem Cell Therapy 10/22/10 Detroit
Exelixis Gets $60M from Bristol, Genentech Surpasses Original Herceptin, Synosia Pockets $30M, & More Bay Area Life Sciences News 10/15/10 San Francisco
Fate Therapeutics Snags Deal With Becton Dickinson to Market Stem Cell Technology 10/14/10 San Diego
Onyx Delays FDA Push, Vega Aims High Against Diabetes, Stanford Biologist Goes Open Source, & More Bay Area Life Sciences News 10/08/10 San Francisco
Sage Attracts Bigwigs, Hutch Adds Immunotherapy Center, the Pro-Life Vaccine Firm, & More Seattle-Area Life Sciences News 10/07/10 Seattle
ModeRNA, Stealth Startup Backed By Flagship, Unveils New Way to Make Stem Cells 10/04/10 Boston
Page 3 of 7 « previous page · next page »